Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Venous Thromboembolism

Venous Thromboembolism Key PointsQuestionWhat advances in diagnosis and treatment of venous thromboembolism have occurred in the past 5 years? FindingsAlternative approaches have been developed for improvement and simplification of currently recommended diagnostic algorithms and for assessment of specific subgroups. The introduction of direct oral anticoagulants has resulted in simplified treatment of venous thromboembolism with a lower risk of bleeding. Decisions on initiation and duration of therapy can now be more carefully implemented. MeaningAdvances in diagnosis and treatment enabled more patient-specific management of venous thromboembolism. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Venous Thromboembolism

Download PDF
21 pages
Read Article

Loading next page...
 
/lp/american-medical-association/venous-thromboembolism-05j1NtSwZ2
Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2018.14346
pmid
30326130
Publisher site
See Article on Publisher Site

Abstract

Key PointsQuestionWhat advances in diagnosis and treatment of venous thromboembolism have occurred in the past 5 years? FindingsAlternative approaches have been developed for improvement and simplification of currently recommended diagnostic algorithms and for assessment of specific subgroups. The introduction of direct oral anticoagulants has resulted in simplified treatment of venous thromboembolism with a lower risk of bleeding. Decisions on initiation and duration of therapy can now be more carefully implemented. MeaningAdvances in diagnosis and treatment enabled more patient-specific management of venous thromboembolism.

Journal

JAMA – American Medical Association

Published: Oct 16, 2018

References

  • A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study
    Anderson, FA; Wheeler, HB; Goldberg, RJ
  • Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study
    Silverstein, MD; Heit, JA; Mohr, DN; Petterson, TM; O’Fallon, WM; Melton, LJ
  • Incidence and mortality of venous thrombosis: a population-based study
    Naess, IA; Christiansen, SC; Romundstad, P; Cannegieter, SC; Rosendaal, FR; Hammerstrøm, J
  • Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort
    Tagalakis, V; Patenaude, V; Kahn, SR; Suissa, S
  • Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE Study (1985-2009)
    Huang, W; Goldberg, RJ; Anderson, FA; Kiefe, CI; Spencer, FA
  • Analysis of national trends in admissions for pulmonary embolism
    Smith, SB; Geske, JB; Kathuria, P
  • Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications: a systematic review and meta-analysis of the management outcome studies
    Carrier, M; Righini, M; Wells, PS
  • Trends in case fatality rate in pulmonary embolism according to stability and treatment
    Stein, PD; Matta, F; Alrifai, A; Rahman, A
  • Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates
    Mahan, CE; Borrego, ME; Woersching, AL
  • Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report
    Kearon, C; Akl, EA; Ornelas, J
  • Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
    Shea, BJ; Grimshaw, JM; Wells, GA
  • Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH
    Dronkers, CEA; van der Hulle, T; Le Gal, G
  • Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH
    Dronkers, CEA; Ende-Verhaar, YM; Kyrle, PA
  • Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis
    Geersing, GJ; Zuithoff, NP; Kearon, C
  • Wells rule and D-dimer testing to rule out pulmonary embolism: a systematic review and individual-patient data meta-analysis
    van Es, N; van der Hulle, T; van Es, J
  • Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
    Bates, SM; Jaeschke, R; Stevens, SM
  • 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism
    Konstantinides, SV; Torbicki, A; Agnelli, G
  • Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology Working Groups of Aorta and Peripheral Circulation and Pulmonary Circulation and Right Ventricular Function [published online February 17, 2017]
    Mazzolai, L; Aboyans, V; Ageno, W
  • Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism
    Kline, JA; Mitchell, AM; Kabrhel, C; Richman, PB; Courtney, DM
  • Pulmonary Embolism Rule-Out Criteria (PERC) in pulmonary embolism—revisited: a systematic review and meta-analysis
    Singh, B; Mommer, SK; Erwin, PJ; Mascarenhas, SS; Parsaik, AK
  • More on: clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism
    Righini, M; Le Gal, G; Perrier, A; Bounameaux, H
  • The Pulmonary Embolism Rule-Out Criteria (PERC) rule does not safely exclude pulmonary embolism
    Hugli, O; Righini, M; Le Gal, G
  • Pulmonary Embolism Rule-Out Criteria (PERC) rule in European patients with low implicit clinical probability (PERCEPIC): a multicentre, prospective, observational study
    Penaloza, A; Soulié, C; Moumneh, T
  • Effect of the Pulmonary Embolism Rule-Out Criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial
    Freund, Y; Cachanado, M; Aubry, A
  • Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study
    van der Hulle, T; Cheung, WY; Kooij, S
  • Accuracy of emergency physician-performed ultrasonography in the diagnosis of deep-vein thrombosis: a systematic review and meta-analysis
    Pomero, F; Dentali, F; Borretta, V
  • The diagnostic accuracy of magnetic resonance venography in the detection of deep venous thrombosis: a systematic review and meta-analysis
    Abdalla, G; Fawzi Matuk, R; Venugopal, V
  • Diagnostic characteristics of lower limb venous compression ultrasonography in suspected pulmonary embolism: a meta-analysis
    Da Costa Rodrigues, J; Alzuphar, S; Combescure, C; Le Gal, G; Perrier, A
  • Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: a bivariate meta-analysis
    Squizzato, A; Pomero, F; Allione, A
  • Planar and SPECT ventilation/perfusion imaging and computed tomography for the diagnosis of pulmonary embolism: a systematic review and meta-analysis of the literature, and cost and dose comparison
    Phillips, JJ; Straiton, J; Staff, RT
  • Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
    Aujesky, D; Roy, PM; Verschuren, F
  • Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study
    Zondag, W; Mos, IC; Creemers-Schild, D
  • Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis
    Piran, S; Le Gal, G; Wells, PS
  • Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs
    Lozano, F; Trujillo-Santos, J; Barrón, M
  • Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH
    Kearon, C; Ageno, W; Cannegieter, SC; Cosmi, B; Geersing, GJ; Kyrle, PA
  • Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
    Schulman, S; Kearon, C
  • Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis
    Gómez-Outes, A; Terleira-Fernández, AI; Lecumberri, R; Suárez-Gea, ML; Vargas-Castrillón, E
  • Case fatality rates of recurrent thromboembolism and bleeding in patients receiving direct oral anticoagulants for the initial and extended treatment of venous thromboembolism: a systematic review
    Gómez-Outes, A; Lecumberri, R; Suárez-Gea, ML; Terleira-Fernández, AI; Monreal, M; Vargas-Castrillón, E
  • Drugs for treatment and prevention of venous thromboembolism
  • Warfarin initiation nomograms for venous thromboembolism
    Garcia, P; Ruiz, W; Loza Munárriz, C
  • Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials
    Li, X; Yang, J; Wang, X; Xu, Q; Zhang, Y; Yin, T
  • Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
    Verbelen, M; Weale, ME; Lewis, CM
  • Comparison table: some oral anticoagulants for VTE [published October 16, 2018]
  • Thrombolysis for acute deep vein thrombosis
    Watson, L; Broderick, C; Armon, MP
  • Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis
    Vedantham, S; Goldhaber, SZ; Julian, JA
  • Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis
    Engelberger, RP; Spirk, D; Willenberg, T
  • Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial
    Engelberger, RP; Stuck, A; Spirk, D
  • Thrombolytic therapy for pulmonary embolism
    Hao, Q; Dong, BR; Yue, J; Wu, T; Liu, GJ
  • Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism
    Riva, N; Puljak, L; Moja, L
  • Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism
    Konstantinides, SV; Vicaut, E; Danays, T
  • Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial
    Mismetti, P; Laporte, S; Pellerin, O
  • Association of inferior vena cava filter placement for venous thromboembolic disease and a contraindication to anticoagulation with 30-day mortality
    Turner, TE; Saeed, MJ; Novak, E; Brown, DL
  • Association between contemporary trends in inferior vena cava filter placement and the 2010 US Food and Drug Administration advisory
    Reddy, S; Lakhter, V; Zack, CJ; Zhao, H; Chatterjee, S; Bashir, R
  • Effect of compression stockings on post thrombotic syndrome in patients with deep vein thrombosis: a meta-analysis of randomised controlled trials
    Subbiah, R; Aggarwal, V; Zhao, H; Kolluri, R; Chatterjee, S; Bashir, R
  • Edoxaban for the treatment of cancer-associated venous thromboembolism
    Raskob, GE; van Es, N; Verhamme, P
  • Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)
    Young, AM; Marshall, A; Thirlwall, J
  • Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
    Khorana, AA; Noble, S; Lee, AYY
  • Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis
    Franco, L; Giustozzi, M; Agnelli, G; Becattini, C
  • Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial
    Righini, M; Galanaud, JP; Guenneguez, H
  • D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study
    Palareti, G; Cosmi, B; Legnani, C
  • D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study
    Kearon, C; Spencer, FA; O’Keeffe, D
  • Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
    Rodger, MA; Kahn, SR; Wells, PS
  • Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study
    Rodger, MA; Le Gal, G; Anderson, DR
  • Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)
    Tosetto, A; Iorio, A; Marcucci, M
  • Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model
    Eichinger, S; Heinze, G; Jandeck, LM; Kyrle, PA
  • Extended anticoagulant and aspirin treatment for the secondary prevention of thromboembolic disease: a systematic review and meta-analysis
    Marik, PE; Cavallazzi, R
  • Rivaroxaban or aspirin for extended treatment of venous thromboembolism
    Weitz, JI; Lensing, AWA; Prins, MH
  • Extended use of dabigatran, warfarin, or placebo in venous thromboembolism
    Schulman, S; Kearon, C; Kakkar, AK
  • Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism
    Büller, HR; Décousus, H; Grosso, MA
  • Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study
    Raskob, G; Ageno, W; Cohen, AT
  • Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism
    Kearon, C; Ginsberg, JS; Kovacs, MJ
  • Apixaban for extended treatment of venous thromboembolism
    Agnelli, G; Buller, HR; Cohen, A
  • Idarucizumab for dabigatran reversal—full cohort analysis
    Pollack, CV; Reilly, PA; van Ryn, J
  • Andexanet alfa for acute major bleeding associated with factor Xa inhibitors
    Connolly, SJ; Milling, TJ; Eikelboom, JW
  • Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
    van Es, N; Coppens, M; Schulman, S; Middeldorp, S; Büller, HR

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial